Immunological markers of ageing;Marcadores inmunológicos de envejecimiento

Revista Espanola de Geriatria y Gerontologia

Volumn 43, Issue 3, 2008, Pages 167-179

  Alonso Fernández, Patricia ^a   De La Fuente, Mónica ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Ageing; Biomarkers; Immune function; Longevity; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER;

AGING; BIOLOGY; CONCEPT ANALYSIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INNATE IMMUNITY; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; REVIEW;

EID: 44349188678     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/S0211-139X(08)71177-6     Document Type: Review

References (194)

1. De Magalhaes JP. Open-minded scepticism: inferring the causal mechanisms of human ageing from genetic perturbations. Ageing Res Rev. 2005;4:1-22.
2. Miquel J. Envejecimiento fisiológico, celular y subcelular. En: Lelois S, Ochoa S, Oro J, Sols A, editores. Bioquímica y Biológica Molecular. Barcelona: Salvat; 1986. p. 241-8.
3. Miquel J, Ecónomos AC, Fleming, Yohnson JE Jr. Mitochondrial role in cell aging. Exp Gerontol. 1980;15:575-91.
4. Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc. 1990;65:375-98.
5. Walford L. The immunologic Theory of Aging. Baltimore: Williams & Wilkins; 1969. p. 70-5.
6. Makinodan T, Kay MM. Age influence on the immune system. Adv Immunol. 1980;29:287-330.
7. Strehler BL, Mildvan AS. General theory of mortality and aging. Science. 1960;132:14-21.
8. De la Fuente M, Herranz A, Vallejo MC. The immune system in the oxidation stress conditions of aging and hypertension. Favorable effects of antioxidants and physical exercise. Antiox Redox Signal. 2005;7:1356-66.
9. Miquel J. An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells. Arch Gerontol Geriatr. 1991;12:99-117.
10. Harman D. Aging: a theory based on free radicals and radiation chemistry. J Gerontol. 1956;11:298-300.
11. Borkan A, Norris AH. Assessment of biological age using a profile of physiological parameters. J Gerontol. 1980;35:177-84.
12. McFarland RA. Human factors in air transportation: occupational health and safety. New York: McGraw-Hil; 1953.
13. Comfort A. Test-battery to measure ageing-rate in man. Lancet. 1969;2:1411-4.
14. Singh MA. Exercise and aging. Clin Geriatr Med. 2004;20:201-21.
15. Sohal RS, Toy PL, Allen RG. Relationship between life expentancy, endogenous antioxidants and products of oxygen free radical reactions in the housefly, Musca domestica. Mech Ageing Dev. 1986;36:71-7.
16. Farmer KJ, Sohal RS. Relationship between superoxide anion radical generation and aging in the housefly, Musca domestica. Free Radic Biol Med. 1989;7:23-9.
17. Baker GT, Sprott RL. Biomarkers of aging. Exp Gerontol. 1988;23:223-39.
18. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005;579:2035-9.
19. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbility and mortality in subjects over 60. J Gerontol. 1990;45:45-98.
20. Mollinedo F, Borregaard N, Boxer LA. Novel trends in neutrophil structure, function and development. Immunol Today. 1999;20:535-7.
21. Simon SO, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Ann Rev Biomed Eng. 2005;7:151-85.
22. Zhelev DV, Alteraifi AM, Chodniewicz D. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants. Biophys J. 2004;87:688-95.
23. Van den Berg JM, Weryer S, Weening JJ, Roos D, Kuijpers TW. Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol. 2001;69:467-73.
24. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci. 1993;18:43-7.
25. Corberand J, Ngyen F, Laharrague P, Fontaniles AM, Gleyzer B, Gyrard E, et al. Polymorphonuclear functions and aging in humans. J Am Geriat Soc. 1981;29:391-7.
26. Former MA, Collazos ME, Barriga C, De la Fuente M, Rodriguez AB, Ortega E. Effect of age on adherence and chemotaxis capacities of peritoneal macrophages. Influence of physical activity stress. Mech Aging Dev. 1994;75:179-89.
27. Di Lorenzo G, Balistreri CR, Candore G, Cigna D, Colombo A, Romano GC, et al. Granulocyte and natural killer activity in the elderly. Mech Ageing Dev. 1999;108:25-38.
28. Wenish C, Patruta S, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil function. J Leukocyte Biol. 2000;67:40-5.
29. Ferrandez MD, De la Fuente M. Effects of age, sex and physical exercise on the phagocytic process of murine peritoneal macrophages. Acta Physiol Scand. 1999;166:47-53.
30. Guayerbas N, De La Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Com Immunol. 2003;27:339-50.
31. Egger G, Burda A, Mitterhammer H, Baumann G, Bratschitsch G, Glasner A. Impaired blood polymorphonuclear leukocyte migration and infection risk in severe trauma. J Infect. 2003;47:148-54.
32. Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T. Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology. 2003;49:293-300.
33. Alvarez E, Ruiz-Gutierrez V, Sobrino F, Santa-María C. Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peripheral neutrophils. Clin Exp Immunol. 2001;124:95-102.
34. Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J. 2004;18:320-2.
35. Niwa Y, Kasama T, Miyachi Y, Kanh T. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging, cross-sectional and longitudinal studies. Life Sci. 1989;44:1655-64.
36. Guayerbas N, Puerto M, Víctor VM, Miquel J, De la Fuente M. Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol. 2002;37:249-56.
37. Alonso P. Estudio del perfil inmunológico en individuos centenarios. Tesis doctoral. Universidad Complutense de Madrid, 2006.
38. Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, et al. Senescence in innate immune responses, reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. 2001;70:881-6.
39. De la Fuente M, Hernanz A, Guayerbas N, Alvarez P, Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell Mol Biol. 2004;50:683-90.
40. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunesenescence. Mech Ageing Dev. 2001;122:1521-35.
41. Tortorella C, Piazzolla G, Spaccavento F, Vella F, Pace L, Antonaci S. Regulatory role of extracellular matrix proteins in neutrophil respiratory burst during aging. Mech Ageing Dev. 2000;119:69-82.
42. Göçer P, Gürer US, Erten N, Palandeiz S, Rayaman E, Akarsu B, et al. Comparison of polymorphonuclear leukocyte functions in elderly patients and healthy young volunteers. Med Princ Pract. 2005;14:382-5.
43. Guayerbas N, Catalán M, Víctor VM, Miquel J, De la Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res. 2002;134:41-8.
44. Papazahariadou M, Athanasiadis GI, Papadopoulos E, et al. Involvement of NK cells against tumors and parasites. Int J Biol Markers. 2007;22:144-53.
45. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71:173-83.
46. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine. 2000;18:1613-20.
47. Mariani E, Roda P, Mariani AR, Vitale M, Degrassi A, Papa S, et al. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin Exp Immunol. 1990;81:479-84.
48. Ferrandez MD, Correa R, Del Rio M, De la Fuente M. Effects in vitro of several antioxidants on the natural killer function of aging mice. Exp Gerontol. 1999;34:675-85.
49. Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. 1997;84:269-75.
50. Heller DA, Ahern FM, Stout JT, McClearn GE. Mortality and biomarkers of aging in heterogeneous stock (HS) mice. J Gerontol A Biol Sci Med Sci. 1998;53:B217-30.
51. Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol. 2001;124:392-7.
52. Remarque E, Pawelec G. T cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol. 1998;8:5-14.
53. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Decreased natural killer cell activity is associated with atherosclerosis in elderly humans. Exp Gerontol. 2001;37:127-36.
54. Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Macha M, Mysliwski A. mmunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol. 2004;39:1447-58.
55. Mariani E, Ravaglia G, Meneghetti A, Tarozzi A, Folti P, Maioli F, et al. Natural immunity and bone and muscle remodelling hormones in the elderly. Mech Ageing Dev. 1998;102:279-92.
56. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, et al. Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol. 1999;116:19-27.
57. Ravaglia G, Forti P, Maioli F, Bastagli L, Facchini A, Mariano E, et al. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged ≥ 90 y. Am J Clin Nutr. 2000;71:590-8.
58. Franceschi C, Monti D, Sansoni P, Cossariza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. 1995;16:12-6.
59. Sansoni P, Brianti V, Fagnoni F, Snelli G, Marcato A, Passeri G, et al. NK cell activity and T-lymphocyte proliferation in healthy centenarians. Ann N Y Acad Sci. 1992;663:505-7.
60. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev. 2005;205:257-68.
61. Nociari MM, Telford W, Russo C. Postthymic development of CD28-CD8+ T cell subset: age-associated expansion and shift from memory to naive phenotype. J Immunol. 1999;162:3327-35.
62. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005;205:72-93.
63. Clambey ET, Van Dyk LF, Kappler JW, Marrack P. Non-malignant clonal expansions of CD8+ memory T cells in aged individuals. Immunol Rev. 2005;205:170-89.
64. Pawelec G, Effros RB, Caruso C, Remarque E, Barnett Y, Solana R. T cells and aging. Front Biosci. 1999;4:D216-69.
65. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today. 2000;21:515-21.
66. De la Fuente M. Effects of antioxidants on immune system ageing. Eur J Clin Nutr. 2002;56:S5-8.
67. Villarrubia VG, Navarro SR. Inmunopatologenia del envejecimiento: el deterioro de la inmunidad innata y su repercusión sobre la inmunidad específica. Restauración por AM3. Rev Esp Geriatr Gerontol. 2000;35;30-42.
68. Frasca D, Nguyen D, Riley RL, Blomberg BB. Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells. Mech Ageing Dev. 2003;124:361-9.
69. Weksler ME. Changes in the B-cell repertoire with age. Vaccine. 2000;18:1624-8.
70. Shodell M, Siegal FP. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol. 2002;56:518-21.
71. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci. 1995;50:B378-82.
72. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev. 2005;205:257-8.
73. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Losgren S, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci. 2005;60:556-65.
74. Koch S, Solana R, De la Rosa O, Pawelec G. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech Ageing Dev. 2006;127:538-43.
75. Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Lofgren S, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006;127:695-704.
76. Nilsson BO, Ernerudh J, Johansson B, Evrin B, Lofgren S, Ferguson F, et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev. 2003;124:469-76.
77. De la Fuente M, Victor VM. Anti-oxidants as modulators of immune function. Immunol Cell Biol. 2000;78:49-54.
78. Ortega E, Garcia JJ, De La Fuente M. Ageing modulates some aspects of the non-specific immune response of murine macrophages and lymphocytes. Exp Physiol. 2000;85:519-25.
79. Esparza B, Sanchez M, Ruiz M, Barranquero M, Sabino E, Merino F. Neutrophil function in elderly persons assessed by flow cytometry. Immunol Invest. 1996;25:185-90.
80. De la Fuente M, Miquel J, Catalan MP, Victor VM, Guayerbas N. The amount of thiolic antioxidant ingestión hended to improve several immune functios is higher in aged than in adult mice. Free Rad Research. 2002;36:119-26.
81. Miles EA, Thies F, Wallace FA, Powell JR, HUrst TL, Newsholme EA, et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci. 2001;100:91-100.
82. Yu BP, Chung HY. Oxidative stress and vascular aging. Diabetes Res Clin Pract. 2001;54:S73-80.
83. De la Fuente M, Baeza I, Guayerbas N, PuertoM, Castillo C, Salazar V, et al. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology. 2004;5:389-400.
84. Straub RH, Miller LE, Schölmerich J, Zietz B. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol. 2000;109:10-5.
85. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ramberg K, Pedersen AN, Skinhoj P, et al. Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans? Clin Exp Immunol. 2002;127:107-14.
86. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TC. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology. 1996;42:69-78.
87. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, et al. T cells and aging, January 2002 update. Front Biosci. 2002;7:1056-183.
88. Solana R, Villanueva JL, Peña J, De la Fuente M. Cell mediated immunity in ageing. Comp Biochem Physiol. 1991;A99:1-4.
89. Flurkey K, Miller RA, Harrison DE. Cellular determinants of age-related decrements in the T-cell mitogen response of B6CBAF1 mice. J Gerontol. 1992;47:B115-20.
90. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production. Clin Exp Immunol. 2000;119:433-40.
91. Candore G, Di Lorenzo G, Caruso C, MOdica M, Colucci A, Crescimano G, et al. The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2. Mech Ageing Dev. 1992;63:297-307.
92. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-81.
93. Forsey RJ, Thompson JM, Ernerudh J, Hurst TL, Strindhall J, Johanson B, et al. Plasma cytokine profiles in elderly humans. Mech Ageing Dev. 2003;124:487-93.
94. Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab. 2006;290:E961-7.
95. Ferrari SL, Karasik D, Liu J, Karamohamed AG, Cupples LA, Kiel DP, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Miner Res. 2004;19:552-9.
96. Pfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23:90-119.
97. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab. 1998;83:2012-7.
98. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55:M709-15.
99. Cesari M, Penninx BW, Pahor M, Laurebani F, Cousi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242-8.
100. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50:1268-71.
101. Ferrucci L, Harris TB, Guralnik JM, Tracy R, Corti M, Colan H, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-46.
102. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-12.
103. Huang H, Patel DD, Manton KG. The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci. 2005;10:192-215.
104. Gupta S, Gollapudi S. Molecular mechanisms of TNF-alpha-induced apoptosis in naive and memory T cell subsets. Autoimmun Rev. 2006;5:264-8.
105. Screaton G, Xu XN. T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol. 2000;12:316-22.
106. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Ann Rev Immunol. 1994;12:141-79.
107. Corsini E, Battaini F, Lucchi L, Marinovich M, Racchi M, Govoni S, et al. A defective protein kinase C anchoring system underlying age-associated impairment in TNF-α production in rat macrophages. J Immunol. 1999;163:3468-73.
108. Zissel G, Schlaak M, Müller-Quernheim J. Age-related decrease in accesory cell function of human alveolar macrophages. J Invest Med. 1999;47:51-6.
109. Pedersen B, Bruunsgaard H, Ostrowski K, Krabbe K, Hansen H, Krzywkowski K, et al. Cytokines in aging and exercise. Int J Sports Med. 2000;21:S4-21.
110. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunosenescence. Mech Ageing Dev. 2001;122:1521-35.
111. De la Fuente M, Del Río M, Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol. 2001;116:158-167.
112. Puerto M, Guayerbas N, Álvarez P, De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neroimmunol. 2005;165:33-40.
113. Bruunsgard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci. 1999;54:M357-64.
114. Bruunsgard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK. Ageing, TNF-alpha and atherosclerosis. Clin Exp Immunol. 2000;21:255-60.
115. Bruunsgard H, Andersen-Ranberg K, Hjelmborg J, Klarlund Pedersen B, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003;115:278-83.
116. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996;273:59-63.
117. Miquel J. An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol. 1998;33:113-26.
118. Sastre J, Pallardó FV, Viña J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med. 2003;35:1-8.
119. Barja G. Free radicals and aging. Trends Neurosci. 2004;27:595-600.
120. Bokov A, Chaudhuri A, Richardson A. The role of oxidative damage and stress in aging. Mech Ageing Dev. 2004;125:811-26.
121. Barja G, Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the Herat and brain of mammals. FASEB J. 2000;14:312-8.
122. Irshad M, Chaudhuri PS. Oxidant-antioxidant system: Role and significance in human body. Indian J Exp Biol. 2002;40:1233-9.
123. Perez Druso D, Strobel P, Foncea R, Diez MS, VAsquez L, Urquiaga J, et al. Wine, diet, antioxidant defences and oxidative damage. Ann N Y Acad Sci. 2002;957:136-45.
124. Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behaviour: Beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr. 2005;81:S313-6.
125. Ward WF, Qi W, Van Remmen H, Zackert WE, Roberts JL 2nd, Richardson A. Effects of age and caloric restriction on lipid peroxidation: Measurement of oxidative stress by F2-isoprostane levels. J Gerontol A Biol Sci Med Sci. 2005;60:845-7.
126. Roberts LJ 2nd, Reckelhoff. Measurement of F(2)-isoprostaness unveils profound oxidative stress in aged rats. Biochem Biophys Res Commun. 2001;287:254-6.
127. Fontana L, Giagulli C, Cominacini L, Fratta Pasini A, Minué P, Lecchi A, et al. Beta2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes. Circulation. 2002;106:2434-41.
128. Cracowski JL, Stanke-Labesque F, Souvignet C, Bessard G. Isoprostanes: New markers of oxidative stress in human diseases. Press Med. 2000;29:604-10.
129. Inal ME, Kanbak G, Sunal E. Antioxidant enzime activities and malondialdehyde levels related to aging. Clin Chim Acta. 2001;305:75-80.
130. Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, et al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res. 2006;40:495-505.
131. Mutlu-Turkoglu U, Ilhan E, Oztezcan S, Kuru A, Aykac-Toker G, Uysal M. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem. 2003;36:397-400.
132. Alvarado C, Alvarez P, Puerto M, Gausserès N, Jiménez L, De la Fuente M. Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition. 2006;22:767-77.
133. Alvarado C, Alvarez P, Jiménez L, De la Fuente M. Oxidative stress in leukocytes from young prematurely aging mice is reversed by supplementation with biscuits rich in antioxidants. Dev Comp Immunol. 2006;30:1168-80.
134. Alvarado C, Álvarez P, Guayerbas N, Puerto M, Jiménez L, De la Fuente M. El daño peroxidativo en leucocitos peritoneales de ratones viejos disminuye suplementando la dieta con galletas enriquecidas con antioxidantes. Relación con la supervivencia. Rev Esp Geriatr Gerontol. 2005;40:362-7.
135. Curzio M, Esterbauer H, Poli G. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React. 1987;9:295-306.
136. Siems W, Capuozzo E, Lucano A, Salerno C, Crifò C. High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2,3-trans-nonenal. Life Sci. 2003;73:2583-90.
137. Siems WG, Capuozzo E, Verginelli D, Salerno C, Crifò C, Grune T. Inhibition of NADPH oxidase-mediated superoxide radical formation in PMA-stimulated human neutrophils by 4-hydroxynonenal - binding to -SH and -NH2 groups. Free Radic Res. 1997;27:353-8.
138. Dianzani C, Parrini M, Ferrara C, Fantozzi R. Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils. Cell Biochem Funct. 1996;14:193-200.
139. Cambiaggi C, Dominici S, Comporti M, Pompella A. Modulation of human T lymphocyte proliferation by 4-hydroxynonenal, the bioactive product of neutrophil-dependent lipid peroxidation. Life Sci. 1997;61:777-85.
140. Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002;33:611-9.
141. Beregi E, Regius O, Rajczy K. Comparative study of the morphological changes in lymphocytes of elderly individuals and centenarians. Age Ageing. 1991;20:55-9.
142. Poon HF, Calabrese V, Sacapagnini G, Butterfield DA. Free radicals and brain aging. Clin Geriat Med. 2004;20:329-59.
143. Requena JR, Levine RL, Stadtman ER. Recent advances in the analysis of oxidized proteins. Aminoacids. 2003;25:221-6.
144. Stadtman ER, Levine RL. Free radical-metiated oxidation of free amino acids and amino acid residues in proteins. Aminoacids. 2003;25:207-8.
145. Calder PC. Branched-chain amino acids and immunity. J Nutr. 2006;136:S288-93.
146. Tsukishiro T, Shimizu Y, Higuchi K, Watanabe A. Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats. J Gastroenterol Hepatol. 2000;15:849-59.
147. Petro TM, Bhattacharjee JK. Effect of dietary essential amino acid limitations upon susceptibility to Salmonella typhimurium and the effect upon humoral and cellular immune response in mice. Infect Immun. 1981;32:251-9.
148. García de Lorenzo A, Ortiz-Leyba C, Planas M, Montejo JC, Núñez R, Ordóñez FJ, et al. Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects. Crit Care Med. 1997;25:418-24.
149. Tom A, Fair KS. Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr. 2006;136:324-30.
150. Stadtman ER. Role of oxidant species in aging. Curr Med Chem. 2004;11:1105-12.
151. Grune T, Shringarpure R, Sitte N, Davies KJA. Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol A Biol Sci Med Sci. 2001;56:B459-67.
152. Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci. 2001;928:22-38.
153. García-Arumí E, Andreu AL, López-Hellín J, Schwartz S. Effect of oxidative stress on lymphocytes from elderly subjects. Clin Sci. 1998;94:447-52.
154. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res. 2000;33:S99-108.
155. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging. 2002;23:795-807.
156. Collins AR, Cadet J, Moller L, Poulsen HE, Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch Biochem Biophys. 2004;423:57-65.
157. Loft S, Fisher-Nielsen A, Jeding IB, Vistisen K, Poulsen HE. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health. 1993;40:391-404.
158. Singh KK. Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci. 2006;1067:182-90.
159. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun. 2003;304:519-29.
160. Sacheck JM, Milbury PE, Cannon JG, Roubenoff R, Blumberg JB. Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic Biol Med. 2003;34:1575-88.
161. Alvarez P, Alvarado C, Mathieu F, Jimenez L, De la Fuente M. Diet supplementation for 5 weeks with polyphenol-rich cereals improves several functions and the redox state of mouse leucocytes. Eur J Nutr. 2006;45:428-38.
162. Randerath K, Putman KL, Osterburg HH, Johnson SA, Morgan DG, Finch CE. Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat Res. 1993;295:11-8.
163. Lee BM, Kwack SJ, Kim HS. Age-related changes in oxidative DNA damage and benzo(a)pyrene diolepoxide-I (BPDE-I)-DNA adduct levels in human stomach. J Toxicol Environ Health A. 2005;68:1599-610.
164. Randerath K, Li DH, Randerath E. Age-related DNA modifications (Icompounds): modulation by physiological and pathological processes. Mutat Res. 1990;238:245-53.
165. Von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med. 2005;5:197-203.
166. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-5.
167. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol. 2000;165:1191-6.
168. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol. 2002;2:699-706.
169. Mariani E, Meneghetti A, Formentini I, Neris S, Cattini L, Ravaglia L, et al. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol. 2003;38:653-9.
170. Goronzy JJ, Fujii H, Weyand CM. Telomeres, immune aging and autoimmunity. Exp Gerontol. 2006;41:246-51.
171. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des. 2005;11:3141-58.
172. Sandström BE, Marklund SL. Effects of variation in glutathione peroxidase activity on DNA damage and cell survival in human cells exposed to hydrogen peroxide and t-butyl hydroperoxide. Biochem J. 1990;271:17-23.
173. Griffith OW, Meister A. Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci U S A. 1985;82:4668-72.
174. Viña J, editor. Glutathione: metabolism and physiological functions. Boca Raton: CRC Press; 1990.
175. Miquel J, Weber H. Aging and increased oxidation of the sulfur pool. En: Viña J, editor. Glutathione: Metabolism and physiological functions. Boca Raton: CRC Press; 1990. p. 187-92.
176. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 1994;8:1131-8.
177. Dröge W, Breitkreutz R. Glutathione and immune function. Proc Nut Soc. 2000;59:595-600.
178. Camera E, Picardo M. Analytical methods to investigate glutathione and related compounds in biological and pathological processes. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;781:181-206.
179. De la Asuncion JG, Millan A, Pla R, Bruseghini L, Esteras A, Pallado FV, et al. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J. 1996;10:333-8.
180. Erden-Inal M, Snal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct. 2002;20:61-6.
181. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med. 2002;33:1290-300.
182. Rebrin I, Kamzalov S, Sohal RS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radic Biol Med. 2003;35:626-35.
183. Gho CG, Kim HJ, Chung SW, Jung KJ, Shim KH, Yu BP, et al. Modulation of glutathione and thioredoxin systems by caloric restriction during the aging process. Exp Gerontol. 2003;38:539-48.
184. Rebrin I, Sohal RS. Comparison of redox thiol state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol. 2004;39:1513-9.
185. Viveros MP, Arranz L, Hernanz A, Miquel J, De la Fuente M. A Model of premature ageing in mice based on altered stress-related behavioural response and immunosenescence. Neuroimmunomodulation. 2007;14:157-62.
186. Kasapoglu M, Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol. 2001;36:209-20.
187. Barnett YA, King CM. An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in humans. Mutat Res. 1995;338:115-28.
188. Saraymen R, Kilic E, Yazar S, Cetin M. Influence of sex and age on the activity of antioxidant enzymes of polymorphonuclear leukocytes in healthy subjects. Yonsei Med J. 2003;44:9-14.
189. Gianni P, Jan KJ, Douglas MJ, Stuart PM, Tarnopolsky MA. Oxidative stress and the mitochondrial theory of aging in human skeletal muscle. Exp Gerontol. 2004;39:1391-400.
190. Perez-Campo R, Lopez-Torres M, Rojas C, Cadenas S, Barja G. Longevity and antioxidant enzymes, non-enzymatic antioxidants and oxidative stress in the vertebrate lung: a comparative study. J Comp Physiol. 1994;163:682-9.
191. Viña J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders. Protective effect of estrogens. Free Rad Res. 2006;40:1359-65.
192. Borrás C, Gambini J, Gómez-Cabrera MC, Sastre J, Pallardó FV, Mann GE, et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell. 2005;4:113-8.
193. Viña J, Borrás C, Gambini J, Sastre J, Pallardó FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett. 2005;579:2541-5.
194. Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci. 2007;12:1008-13.